Skip to main content

Animations

MJFF Publications

5501 - 5510 of 6516 Results
Title
Year
  • Year
  • 2025
  • 2024
  • 2025
  • 2025
  • 2025
  • 2023
  • 2024
  • 2025
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: ZSCAN21 mediates the pathogenic transcriptional induction of α-synuclein in cellular and animal models of Parkinson’s disease
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-025-07722-w
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Topography of Cholinergic Nerve Terminal Vulnerability and Balance Self-Efficacy in Parkinson's Disease
    Journal Name: Journal of Integrative Neuroscience
    Publisher: IMR Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.31083/j.jin2309178
    Citation Count: 3
  • Summary Details
    OPEN
    Title: The impact of REM-sleep behavior disorder on people with Parkinson’s disease and their partners
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-00986-1
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A spatio-temporal brain miRNA expression atlas identifies sex-independent age-related microglial driven miR-155-5p increase
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-025-59860-6
    Citation Count: 5
  • Summary Details
    OPEN
    Title: 14-3-3θ phosphorylation exacerbates alpha-synuclein aggregation and toxicity
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2025.106801
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Evaluating the Utility of REVEL and CADD for Interpreting Variants in Amyotrophic Lateral Sclerosis Genes
    Journal Name: Human Mutation
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2023/8620557
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Increasing hexokinase 1 expression improves mitochondrial and glycolytic functional deficits seen in sporadic Alzheimer’s disease astrocytes
    Journal Name: Molecular Psychiatry
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41380-024-02746-8
    Citation Count: 17
  • Summary Details
    OPEN
    Title: The Exon-Based Transcriptomic Analysis of Parkinson’s Disease
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biom15030440
    Citation Count: 2
  • Summary Details
    OPEN
    Title: The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00896-2
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Four questions to predict cognitive decline in de novo Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00958-5
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.